Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination

Maximizing vaccine efficacy is critical, but previous research has failed to provide a one-size-fits-all solution. Although vitamin A and vitamin D supplementation studies have been designed to improve vaccine efficacy, experimental results have been inconclusive. Information is urgently needed to explain study discrepancies and to provide guidance for the future use of vitamin supplements at the time of vaccination. We conducted a randomized, blinded, placebo-controlled study of influenza virus vaccination and vitamin supplementation among 2 to 8 (inclusive) year old children over three seasons, including 2015–2016 (n = 9), 2016–2017 (n = 44), and 2017–2018 (n = 26). Baseline measurements of vitamins A and D were obtained from all participants. Measurements were of serum retinol, retinol-binding protein (RBP, a surrogate for retinol), and 25-hydroxyvitamin D (25(OH)D). Participants were stratified into two groups based on high and low incoming levels of RBP. Children received two doses of the seasonal influenza virus vaccine on days 0 and 28, either with an oral vitamin supplement (termed A&D; 20,000 IU retinyl palmitate and 2000 IU cholecalciferol) or a matched placebo. Hemagglutination inhibition (HAI) antibody responses were evaluated toward all four components of the influenza virus vaccines on days 0, 28, and 56. Our primary data were from season 2016–2017, as enrollment was highest in this season and all children exhibited homogeneous and negative HAI responses toward the Phuket vaccine at study entry. Responses among children who entered the study with insufficient or deficient levels of RBP and 25(OH)D benefited from the A&D supplement (p < 0.001 for the day 28 Phuket response), whereas responses among children with replete levels of RBP and 25(OH)D at baseline were unaffected or weakened (p = 0.02 for the day 28 Phuket response). High baseline RBP levels associated with high HAI titers, particularly for children in the placebo group (baseline RBP correlated positively with Phuket HAI titers on day 28, r = 0.6, p = 0.003). In contrast, high baseline 25(OH)D levels associated with weak HAI titers, particularly for children in the A&D group (baseline 25(OH)D correlated negatively with Phuket HAI titers on day 28, r = −0.5, p = 0.02). Overall, our study demonstrates that vitamin A&D supplementation can improve immune responses to vaccines when children are vitamin A and D-insufficient at baseline. Results provide guidance for the appropriate use of vitamins A and D in future clinical vaccine studies.

[1]  Beisi Xu,et al.  Complex sex-biased antibody responses: estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers , 2019, International immunology.

[2]  M. Cantorna,et al.  Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis , 2019, Critical reviews in biochemistry and molecular biology.

[3]  G. Neale,et al.  Will Attention by Vaccine Developers to the Host’s Nuclear Hormone Levels and Immunocompetence Improve Vaccine Success? , 2019, Vaccines.

[4]  Beata M. Gruber-Bzura Vitamin D and Influenza—Prevention or Therapy? , 2018, International journal of molecular sciences.

[5]  N. Crum‐Cianflone,et al.  25-hydroxyvitamin D, influenza vaccine response and healthcare encounters among a young adult population , 2018, PloS one.

[6]  B. Boucher,et al.  Why vitamin D clinical trials should be based on 25-hydroxyvitamin D concentrations , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  D. Woodland,et al.  Enhanced CD103 Expression and Reduced Frequencies of Virus-Specific CD8+ T Cells Among Airway Lymphocytes After Influenza Vaccination of Mice Deficient in Vitamins A + D. , 2017, Viral immunology.

[8]  Seemalata Jain,et al.  Low Retinol-Binding Protein and Vitamin D Levels Are Associated with Severe Outcomes in Children Hospitalized with Lower Respiratory Tract Infection and Respiratory Syncytial Virus or Human Metapneumovirus Detection. , 2017, The Journal of pediatrics.

[9]  D. Dowdy,et al.  Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study , 2017, Journal of acquired immune deficiency syndromes.

[10]  B. Flannery,et al.  Are children's vitamin D levels and BMI associated with antibody titers produced in response to 2014–2015 influenza vaccine? , 2017, Human vaccines & immunotherapeutics.

[11]  David A. Jolliffe,et al.  Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data , 2017, British Medical Journal.

[12]  M. Marz,et al.  Differential Effects of Vitamins A and D on the Transcriptional Landscape of Human Monocytes during Infection , 2017, Scientific Reports.

[13]  Xuguang Zhang,et al.  Low Serum Levels of Vitamins A, D, and E Are Associated with Recurrent Respiratory Tract Infections in Children Living in Northern China: A Case Control Study , 2016, PloS one.

[14]  Beisi Xu,et al.  Binding of estrogen receptors to switch sites and regulatory elements in the immunoglobulin heavy chain locus of activated B cells suggests a direct influence of estrogen on antibody expression. , 2016, Molecular immunology.

[15]  Geoffrey Brown,et al.  Regulation of vitamin D receptor expression by retinoic acid receptor alpha in acute myeloid leukemia cells , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  Beisi Xu,et al.  Hotspots for Vitamin-Steroid-Thyroid Hormone Response Elements Within Switch Regions of Immunoglobulin Heavy Chain Loci Predict a Direct Influence of Vitamins and Hormones on B Cell Class Switch Recombination. , 2016, Viral immunology.

[17]  G. Poland,et al.  Vitamin D, leptin and impact on immune response to seasonal influenza A/H1N1 vaccine in older persons , 2016, Human vaccines & immunotherapeutics.

[18]  R. Webby,et al.  Retinol binding protein and vitamin D associations with serum antibody isotypes, serum influenza virus‐specific neutralizing activities and airway cytokine profiles , 2016, Clinical and experimental immunology.

[19]  S. Surman,et al.  Vitamin Supplementation at the Time of Immunization with a Cold-Adapted Influenza Virus Vaccine Corrects Poor Mucosal Antibody Responses in Mice Deficient for Vitamins A and D , 2016, Clinical and Vaccine Immunology.

[20]  G. Poland,et al.  “Let there be light”: the role of vitamin D in the immune response to vaccines , 2015, Expert review of vaccines.

[21]  M. Nowalk,et al.  Do vitamin D levels affect antibody titers produced in response to HPV vaccine? , 2015, Human vaccines & immunotherapeutics.

[22]  R. Compans,et al.  Influenza Virus-Specific Neutralizing IgM Antibodies Persist for a Lifetime , 2014, Clinical and Vaccine Immunology.

[23]  C. Camargo,et al.  Effects of vitamin D supplements on influenza A illness during the 2009 H1N1 pandemic: a randomized controlled trial. , 2014, Food & function.

[24]  P. Carney,et al.  IgM, IgG, and IgA Antibody Responses to Influenza A(H1N1)pdm09 Hemagglutinin in Infected Persons during the First Wave of the 2009 Pandemic in the United States , 2014, Clinical and Vaccine Immunology.

[25]  R. Rudraraju,et al.  Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice. , 2014, Vaccine.

[26]  R. Evans,et al.  Nuclear Receptors, RXR, and the Big Bang , 2014, Cell.

[27]  Anne M Johnson,et al.  Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study , 2014, The Lancet Respiratory Medicine.

[28]  R. Rudraraju,et al.  Intranasal Administration of Retinyl Palmitate with a Respiratory Virus Vaccine Corrects Impaired Mucosal IgA Response in the Vitamin A-Deficient Host , 2014, Clinical and Vaccine Immunology.

[29]  A. Takada,et al.  Comparison of Antiviral Activity between IgA and IgG Specific to Influenza Virus Hemagglutinin: Increased Potential of IgA for Heterosubtypic Immunity , 2014, PloS one.

[30]  M. Bickel,et al.  Immune Response after a Single Dose of the 2010/11 Trivalent, Seasonal Influenza Vaccine in HIV-1–Infected Patients and Healthy Controls , 2013, HIV clinical trials.

[31]  Yuwei Zhu,et al.  Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old. , 2013, Vaccine.

[32]  T. Popow-Kraupp,et al.  Validation of the modified hemagglutination inhibition assay (mHAI), a robust and sensitive serological test for analysis of influenza virus-specific immune response. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[33]  S. Esposito,et al.  Impact of vitamin D administration on immunogenicity of trivalent inactivated influenza vaccine in previously unvaccinated children , 2013, Human vaccines & immunotherapeutics.

[34]  K. Hartshorn,et al.  The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. , 2013, The Journal of general virology.

[35]  D. Woodland,et al.  Reduced Frequencies and Heightened CD103 Expression among Virus-Induced CD8+ T Cells in the Respiratory Tract Airways of Vitamin A-Deficient Mice , 2012, Clinical and Vaccine Immunology.

[36]  M. Fakih,et al.  Effect of 25‐hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients , 2011, The Prostate.

[37]  John H. White Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: Past, present and future , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[38]  Stephen W Byers,et al.  Cross-regulation of signaling pathways: an example of nuclear hormone receptors and the canonical Wnt pathway. , 2010, Experimental cell research.

[39]  R. Chesney Vitamin D and The Magic Mountain: the anti-infectious role of the vitamin. , 2010, The Journal of pediatrics.

[40]  M. Urashima,et al.  Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. , 2010, The American journal of clinical nutrition.

[41]  G. Brent,et al.  Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation , 2010, Trends in Endocrinology & Metabolism.

[42]  F. Clavel-Chapelon,et al.  Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study , 2010, BMJ : British Medical Journal.

[43]  B. Cunha,et al.  A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections , 2009, Epidemiology and Infection.

[44]  C. Camargo,et al.  Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. , 2009, Archives of internal medicine.

[45]  J. Mora,et al.  Vitamin effects on the immune system: vitamins A and D take centre stage , 2008, Nature Reviews Immunology.

[46]  J. Aloia,et al.  Re: epidemic influenza and vitamin D. , 2007, Epidemiology and infection.

[47]  P. Lipsky,et al.  Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation , 2007, The Journal of Immunology.

[48]  A. Ross Vitamin A supplementation and retinoic acid treatment in the regulation of antibody responses in vivo. , 2007, Vitamins and hormones.

[49]  John H. White,et al.  Convergence of vitamin D and retinoic acid signalling at a common hormone response element , 2006, EMBO reports.

[50]  W. Fawzi,et al.  Effects of Vitamin A Supplementation on Immune Responses and Correlation with Clinical Outcomes , 2005, Clinical Microbiology Reviews.

[51]  S. Filteau,et al.  Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y , 2004, European Journal of Clinical Nutrition.

[52]  J. Baeten,et al.  Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response. , 2004, The American journal of clinical nutrition.

[53]  N. Noy,et al.  Retinoic Acid Is a High Affinity Selective Ligand for the Peroxisome Proliferator-activated Receptor β/δ* , 2003, Journal of Biological Chemistry.

[54]  H. Saha,et al.  Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[55]  K. Edwards,et al.  Effect of vitamin A therapy on serologic responses and viral load changes after influenza vaccination in children infected with the human immunodeficiency virus. , 2000, The Journal of pediatrics.

[56]  D. Hoover,et al.  Evaluation of plasma retinol-binding protein as a surrogate measure for plasma retinol concentrations , 2000, Scandinavian journal of clinical and laboratory investigation.

[57]  D. Mahalanabis,et al.  Simultaneous vitamin A administration at routine immunization contact enhances antibody response to diphtheria vaccine in infants younger than six months. , 1999, The Journal of nutrition.

[58]  A. Osterhaus,et al.  Integration of vitamin A supplementation with the expanded program on immunization does not affect seroconversion to oral poliovirus vaccine in infants. , 1999, The Journal of nutrition.

[59]  J. Kriesel,et al.  Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. , 1999, Vaccine.

[60]  M. Makishima,et al.  Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells. , 1999, Biochemical pharmacology.

[61]  C. Winrow,et al.  Cross-talk between Orphan Nuclear Hormone Receptor RZRα and Peroxisome Proliferator-activated Receptor α in Regulation of the Peroxisomal Hydratase-Dehydrogenase Gene* , 1998, The Journal of Biological Chemistry.

[62]  L. Moulton,et al.  Randomised trial to assess benefits and safety of vitamin A supplementation linked to immunisation in early infancy , 1998, The Lancet.

[63]  C. Winrow,et al.  Cross-talk between orphan nuclear hormone receptor RZRalpha and peroxisome proliferator-activated receptor alpha in regulation of the peroxisomal hydratase-dehydrogenase gene. , 1998, The Journal of biological chemistry.

[64]  H. Whittle,et al.  Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa , 1997, The Lancet.

[65]  C. Meier Regulation of gene expression by nuclear hormone receptors. , 1997, Journal of receptor and signal transduction research.

[66]  S. Teitelbaum,et al.  Competition for a Unique Response Element Mediates Retinoic Acid Inhibition of Vitamin D3-stimulated Transcription* , 1996, The Journal of Biological Chemistry.

[67]  W. Wahli,et al.  Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. , 1995, Molecular endocrinology.

[68]  A. Sommer,et al.  Reduced seroconversion to measles in infants given vitamin A with measles vaccination , 1995, The Lancet.

[69]  J. Franklyn,et al.  Physiology of the steroid-thyroid hormone nuclear receptor superfamily. , 1994, Bailliere's clinical endocrinology and metabolism.

[70]  A. Sommer Vitamin A, infectious disease, and childhood mortality: a 2 solution? , 1993, The Journal of infectious diseases.

[71]  J. Y. Chen,et al.  Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors. , 1993, The Journal of biological chemistry.

[72]  A. Sommer,et al.  Depressed immune response to tetanus in children with vitamin A deficiency. , 1992, The Journal of nutrition.

[73]  K. Aziz,et al.  Failure of a large dose of vitamin A to enhance the antibody response to tetanus toxoid in children. , 1980, The American journal of clinical nutrition.

[74]  D. Goodman,et al.  Retinol-binding protein: the transport protein for vitamin A in human plasma. , 1968, The Journal of clinical investigation.